| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P356 | DOI | 10.1111/BJD.12670 |
| P8608 | Fatcat ID | release_jn5f4jdm5vh2xg5yxayovncsze |
| P698 | PubMed publication ID | 24117435 |
| P2093 | author name string | A W Armstrong | |
| C T Harskamp | |||
| E J Armstrong | |||
| J S Dhillon | |||
| P2860 | cites work | Bias in meta-analysis detected by a simple, graphical test | Q24685585 |
| Global epidemiology of psoriasis: a systematic review of incidence and prevalence | Q26991871 | ||
| Operating characteristics of a rank correlation test for publication bias | Q27860653 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting | Q27861077 | ||
| Psoriasis and hypertension severity: results from a case-control study | Q33867611 | ||
| Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis | Q33914448 | ||
| Smoking and risk of incident psoriatic arthritis in US women | Q34266162 | ||
| Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys | Q34294642 | ||
| The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies | Q34318384 | ||
| Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis | Q34327755 | ||
| Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. | Q34478064 | ||
| Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. | Q34558876 | ||
| Risk factors for psoriasis: A case-control study | Q34608530 | ||
| Smoking and risk of incident psoriasis among women and men in the United States: a combined analysis | Q35896544 | ||
| Systemic effects of smoking | Q36818050 | ||
| Smoking and the risk of psoriasis in women: Nurses' Health Study II. | Q37227428 | ||
| Smoking and pathogenesis of psoriasis: a review of oxidative, inflammatory and genetic mechanisms | Q37903373 | ||
| The association between psoriasis and dyslipidaemia: a systematic review | Q38056160 | ||
| The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies | Q38064779 | ||
| Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies | Q38077625 | ||
| Incidence and risk factors for psoriasis in the general population | Q38458971 | ||
| Smokers report more psoriasis, but not atopic dermatitis or hand eczema: results from a Norwegian population survey among adults | Q39822868 | ||
| Smoking: health effects and control (1). | Q39825463 | ||
| Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite | Q40917292 | ||
| Smoking and alcohol intake in severely affected patients with psoriasis in Germany | Q43227193 | ||
| Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis | Q43280124 | ||
| Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies | Q43477625 | ||
| Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis | Q43658826 | ||
| Frequent use of tobacco and alcohol in Chinese psoriasis patients | Q44186914 | ||
| Comorbidities associated with psoriasis: an experience from the Middle East | Q44268495 | ||
| Association between alcohol, smoking and HLA-DQA1*0201 genotype in psoriasis | Q45043162 | ||
| Medical history, drug exposure and the risk of psoriasis. Evidence from an Italian case-control study. | Q46793767 | ||
| Relationship between smoking and the clinical severity of psoriasis | Q46859515 | ||
| The relationship between oxidative stress, smoking and the clinical severity of psoriasis. | Q48383097 | ||
| Psoriasis and cardiovascular risk factors: a case-control study on inpatients comparing psoriasis to dermatitis. | Q53086507 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| meta-analysis | Q815382 | ||
| P304 | page(s) | 304-314 | |
| P577 | publication date | 2014-02-01 | |
| P1433 | published in | British Journal of Dermatology | Q4970191 |
| P1476 | title | Psoriasis and smoking: a systematic review and meta-analysis | |
| P478 | volume | 170 |
| Q99567221 | 'Psoriasis 1' reduces T‑lymphocyte‑mediated inflammation in patients with psoriasis by inhibiting vitamin D receptor‑mediated STAT4 inactivation |
| Q33749513 | A Proposal for a Study on Treatment Selection and Lifestyle Recommendations in Chronic Inflammatory Diseases: A Danish Multidisciplinary Collaboration on Prognostic Factors and Personalised Medicine |
| Q36568165 | Antibiotic Exposure, Infection, and the Development of Pediatric Psoriasis: A Nested Case-Control Study |
| Q36378437 | Association Between Inflammatory Skin Disease and Cardiovascular and Cerebrovascular Co-Morbidities in US Adults: Analysis of Nationwide Inpatient Sample Data |
| Q26772143 | Association between Psoriasis and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis |
| Q34793808 | Association between moderate to severe psoriasis and periodontitis in a Scandinavian population |
| Q30252078 | Association between psoriasis and chronic obstructive pulmonary disease: A systematic review and meta-analysis |
| Q39935531 | Association between psoriasis and inflammatory bowel disease: a Danish nationwide cohort study. |
| Q59370664 | Body mass index, abdominal fatness, weight gain and the risk of psoriasis: a systematic review and dose-response meta-analysis of prospective studies. |
| Q47218445 | Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis |
| Q38673099 | Clinical and economic review of secukinumab for moderate-to-severe plaque psoriasis |
| Q30248952 | Co-morbidity in psoriasis: mechanisms and implications for treatment |
| Q41057850 | Cohort study of malignancies and hospitalized infectious events in treated and untreated patients with psoriasis and a general population in the United States. |
| Q40311189 | Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry. |
| Q47224549 | Double trouble: psoriasis and cardiometabolic disorders. |
| Q39053859 | Facing the dilemma of patient-centred psoriasis care: a qualitative study identifying patient needs in dermatological outpatient clinics. |
| Q50094096 | Genetic factors are stressed variably by onset age-based sample selection in psoriasis: A hint from major histocompatibility complex region-based analysis |
| Q96952208 | Impact of immune-mediated diseases in inflammatory bowel disease and implications in therapeutic approach |
| Q50036719 | Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases: protocol for a prospective cohort study of prognostic factors and personalised medicine. |
| Q92208577 | Integrated bioinformatic analysis of differentially expressed genes and signaling pathways in plaque psoriasis |
| Q55547911 | Integrating lifestyle-focused approaches into psoriasis care: improving patient outcomes? |
| Q52900365 | Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis. |
| Q24188109 | Lifestyle changes for treating psoriasis |
| Q30250278 | Management of cardiovascular disease in patients with psoriasis |
| Q48239956 | Metabolic parameters in psoriatic patients treated with interleukin-12/23 blockade (ustekinumab). |
| Q36536235 | Omics for prediction of environmental health effects: Blood leukocyte-based cross-omic profiling reliably predicts diseases associated with tobacco smoking |
| Q34194956 | Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis |
| Q35860158 | Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients |
| Q39012992 | Periodontitis and risk of psoriasis: a systematic review and meta-analysis. |
| Q37644609 | Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional study |
| Q89779252 | Prevalence, Incidence, and Risk of Cancer in Patients With Psoriasis and Psoriatic Arthritis: A Systematic Review and Meta-analysis |
| Q91451261 | Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition |
| Q46180528 | Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment |
| Q38952636 | Psoriasis and Risk of Celiac Disease: A Systematic Review and Meta-analysis |
| Q38629361 | Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity. |
| Q26775609 | Psoriasis and sleep disorders: A systematic review |
| Q53080454 | Psoriasis and smoking: links and risks. |
| Q55332414 | Psoriasis risk in patients with diabetic retinopathy: A nationwide population-based study. |
| Q38210780 | Psoriasis: to treat or to manage? |
| Q93154858 | Risk Factors for the Development of Psoriasis |
| Q40087184 | Risk and predictors of psoriasis in patients with breast cancer: a Swedish population-based cohort study |
| Q40979771 | Risk of Multiple Sclerosis in Patients with Psoriasis: A Danish Nationwide Cohort Study |
| Q41481566 | Smoking and risk for psoriasis: a population-based twin study. |
| Q47644680 | The impact of biologic agents on health-related quality of life outcomes in patients with psoriasis |
| Q92493238 | Use of Secukinumab in a Cohort of Erythrodermic Psoriatic Patients: A Pilot Study |
Search more.